Subcutaneous epcoritamab with rituximab + lenalidomide in patients with relapsed or refractory follicular lymphoma: Phase 1/2 trial update Meeting Abstract
| Authors: | Falchi, L.; Abrisqueta, P.; Nijland, M.; Leppä, S.; Hutchings, M.; Holte, H.; Merryman, R. W.; Lugtenburg, P.; de Vos, S.; Cheah, C. Y.; Christensen, J. H.; Arcaini, L.; Drott, K.; Hellström, M.; Leslie, L. A.; Vitolo, U.; Rana, A.; Abbas, A.; Wang, L.; Dinh, M.; Belada, D. |
| Abstract Title: | Subcutaneous epcoritamab with rituximab + lenalidomide in patients with relapsed or refractory follicular lymphoma: Phase 1/2 trial update |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 1464 |
| End Page: | 1466 |
| Language: | English |
| ACCESSION: | WOS:000893223201195 |
| DOI: | 10.1182/blood-2022-158203 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
